|Printable version||E-mail this to a friend|
EU strengthens its legal arsenal against ISIL/Da'esh and Al-Qaida
On 20 September 2016, the Council adopted a legal framework which, for the first time, will allow the EU to apply sanctions autonomously to ISIL/Da'esh and Al-Qaida and persons and entities associated or supporting them. Until now sanctions could only be applied to persons and entities listed by the United Nations or by EU member states acting individually.
The EU will be able to impose a travel ban on individuals and an asset freeze on individuals and entities that are identified as being associated with ISIL (Da'esh)/ Al-Qaida. This means that all their assets in the EU will be frozen and that EU persons and entities will also be prohibited from making any funds available to listed persons or entities.
The individuals and entities targeted include those who have participated in the planning or perpetrating of terrorist attacks or have provided ISIL (Da'esh)/ Al-Qaida with financing, oil or arms, or have received terrorist training from them. Persons or entities could also be listed for activities such as recruiting; inciting or publicly provoking acts and activitiesin support of these organisations, or being involved in serious abuses of human rights outside the EU, including abduction, rape, sexual violence, forced marriage and enslavement of persons.
The EU will also be able to impose restrictive measures on individuals travelling or seeking to travel both outside the EU, and into the EU, with the aim of supporting, ISIL (Da'esh)/Al-Qaida or receiving training from them. Such measures will target particularly the so-called "foreign fighters". As a result the EU will be able to list any person who meets the criteria - including EU nationals who have supported these organisations outside the EU and who then return. The travel ban will prevent listed persons from entering any EU member state. In the case of a listed EU national, the travel ban will prevent the listed person from travelling to any EU member state other than the member state of which that person is a national.
Upon agreement on listing proposals from member states, persons and entities will be listed through a Council decision and a Council regulation adopted unanimously.
- Response to foreign terrorist fighters and recent terrorist attacks in Europe
- Why and when are EU restrictive measures - 'sanctions' - used?
- Adoption procedure of EU restrictive measures - 'sanctions'
- Council decision concerning restrictive measures against ISIL (Da'esh) and Al-Qaeda and persons, groups, undertakings and entities associated with them and repealing Common Position 2002/402/CFSP
- Council regulutaion imposing additional restrictive measures directed against ISIL (Da'esh) and Al-Qaeda and natural and legal persons, entities or bodies associated with them
Latest News from
Draft guidance on substances in food for infants below 16 weeks21/02/2017 12:44:00
EFSA is launching a public consultation on its new draft guidance on the risk assessment of substances present in food intended for infants below 16 weeks of age.
EU invests €444m in key energy infrastructure20/02/2017 16:05:00
The 18 selected electricity, smart grids and gas projects will contribute to achieving the Energy Union's goals by connecting European energy networks, increasing security of energy supply, and contributing to the sustainable development by integrating renewable energy sources across the EU.
Ombudsman: System of unpaid trainees in EU foreign delegations should end20/02/2017 14:10:00
Following a complaint from a young EU trainee, the European Ombudsman, Emily O'Reilly, has recommended that the European External Action Service pay all of its trainees an appropriate allowance to allow greater access for young people of all backgrounds.
First monoclonal antibody in a veterinary medicine recommended for a marketing authorisation20/02/2017 13:20:00
This is a solution for injection containing the new active substance lokivetmab, the first monoclonal antibody in a veterinary medicine in the EU. It is intended for the treatment of dogs with atopic dermatitis, a common allergic skin disease.